IFN-γ Promotes Muscle Damage in the mdx Mouse Model of Duchenne Muscular Dystrophy by Suppressing M2 Macrophage Activation and Inhibiting Muscle Cell Proliferation

被引:120
|
作者
Villalta, S. Armando [1 ]
Deng, Bo [1 ]
Rinaldi, Chiara [2 ]
Wehling-Henricks, Michelle [2 ]
Tidball, James G. [1 ,2 ,3 ]
机构
[1] Univ Calif Los Angeles, Mol Cellular & Integrat Physiol Program, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
SKELETAL-MUSCLE; ARGININE METABOLISM; INTERFERON-GAMMA; ANTIINFLAMMATORY MEDICATION; REGENERATION; MICE; CALCINEURIN; EXPRESSION; PATHWAY; SYSTEM;
D O I
10.4049/jimmunol.1101267
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Duchenne muscular dystrophy is a degenerative disorder that leads to death by the third decade of life. Previous investigations have shown that macrophages that invade dystrophic muscle are a heterogeneous population consisting of M1 and M2 macrophages that promote injury and repair, respectively. In the present investigation, we tested whether IFN-gamma worsens the severity of mdx dystrophy by activating macrophages to a cytolytic M1 phenotype and by suppressing the activation of proregenerative macrophages to an M2 phenotype. IFN-gamma is a strong inducer of the M1 phenotype and is elevated in mdx dystrophy. Contrary to our expectations, null mutation of IFN-gamma caused no reduction of cytotoxicity of macrophages isolated from mdx muscle and did not reduce muscle fiber damage in vivo or improve gross motor function of mdx mice at the early, acute peak of pathology. In contrast, ablation of IFN-gamma reduced muscle damage in vivo during the regenerative stage of the disease and increased activation of the M2 phenotype and improved motor function of mdx mice at that later stage of the disease. IFN-gamma also inhibited muscle cell proliferation and differentiation in vitro, and IFN-gamma mutation increased MyoD expression in mdx muscle in vivo, showing that IFN-gamma can have direct effects on muscle cells that could impair repair. Taken together, the findings show that suppression of IFN-gamma signaling in muscular dystrophy reduces muscle damage and improves motor performance by promoting the M2 macrophage phenotype and by direct actions on muscle cells. The Journal of Immunology, 2011, 187: 5419-5428.
引用
收藏
页码:5419 / 5428
页数:10
相关论文
共 36 条
  • [1] EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype
    de Carvalho, Samara Camacari
    Apolinario, Leticia Montanholi
    Michelin Matheus, Selma Maria
    Santo Neto, Humberto
    Marques, Maria Julia
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 264 (1-2) : 41 - 47
  • [2] Eosinophils Do Not Drive Acute Muscle Pathology in the mdx Mouse Model of Duchenne Muscular Dystrophy
    Sek, Albert C.
    Moore, Ian N.
    Smelkinson, Margery G.
    Pak, Katherine
    Minai, Mahnaz
    Smith, Roberta
    Ma, Michelle
    Percopo, Caroline M.
    Rosenberg, Helene F.
    JOURNAL OF IMMUNOLOGY, 2019, 203 (02) : 476 - 484
  • [3] Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy
    Percival, Justin M.
    Whitehead, Nicholas P.
    Adams, Marvin E.
    Adamo, Candace M.
    Beavo, Joseph A.
    Froehner, Stanley C.
    JOURNAL OF PATHOLOGY, 2012, 228 (01) : 77 - 87
  • [4] Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy
    Ponzetti, Marco
    Ucci, Argia
    Maurizi, Antonio
    Giacchi, Luca
    Teti, Anna
    Rucci, Nadia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
  • [5] Quantitative assessment of muscle damage in the mdx mouse model of Duchenne muscular dystrophy using polarization-sensitive optical coherence tomography
    Yang, Xiaojie
    Chin, Lixin
    Klyen, Blake R.
    Shavlakadze, Tea
    McLaughlin, Robert A.
    Grounds, Miranda D.
    Sampson, David D.
    JOURNAL OF APPLIED PHYSIOLOGY, 2013, 115 (09) : 1393 - 1401
  • [6] The location of protein oxidation in dystrophic skeletal muscle from the mdx mouse model of Duchenne muscular dystrophy
    Iwasaki, Tomohito
    Terrill, Jessica R.
    Kawarai, Kei
    Miyata, Yusei
    Tagami, Takayoshi
    Maeda, Naoyuki
    Hasegawa, Yasuhiro
    Watanabe, Takafumi
    Grounds, Miranda D.
    Arthur, Peter G.
    ACTA HISTOCHEMICA, 2022, 124 (08)
  • [7] The Effect of Vitamin D Supplementation on Skeletal Muscle in the mdx Mouse Model of Duchenne Muscular Dystrophy
    Debruin, Danielle A.
    Andreacchio, Nicola
    Hanson, Erik D.
    Timpani, Cara A.
    Rybalka, Emma
    Hayes, Alan
    SPORTS, 2019, 7 (05):
  • [8] Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the mdx Mouse Model of Duchenne Muscular Dystrophy
    Guerron, Alfredo D.
    Rawat, Rashmi
    Sali, Arpana
    Spurney, Christopher F.
    Pistilli, Emidio
    Cha, Hee-Jae
    Pandey, Gouri S.
    Gernapudi, Ramkishore
    Francia, Dwight
    Farajian, Viken
    Escolar, Diana M.
    Bossi, Laura
    Becker, Magali
    Zerr, Patricia
    de la Porte, Sabine
    Gordish-Dressman, Heather
    Partridge, Terence
    Hoffman, Eric P.
    Nagaraju, Kanneboyina
    PLOS ONE, 2010, 5 (06):
  • [9] The BALB/c.mdx62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy
    Swiderski, Kristy
    Chan, Audrey S.
    Herold, Marco J.
    Kueh, Andrew J.
    Chung, Jin D.
    Hardee, Justin P.
    Trieu, Jennifer
    Chee, Annabel
    Naim, Timur
    Gregorevic, Paul
    Lynch, Gordon S.
    DISEASE MODELS & MECHANISMS, 2024, 17 (04)
  • [10] Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy
    Rooney, Jachinta E.
    Gurpur, Praveen B.
    Burkin, Dean J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (19) : 7991 - 7996